Ubs Group Ag Biotechnology

Ubs Group Ag

  • $611 Billion
  • Q3 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
BBIO
Bridge Bio Pharma, Inc.
CALL
$201 Million
3.86M
Q3 2025
Reduced 8.04%
NVO
Novo Nordisk A S
PUT
$101 Million
1.82M
Q3 2025
Added 98.71%
MRNA
Moderna, Inc.
CALL
$96.3 Million
3.73M
Q3 2025
Added 21.8%
MRNA
Moderna, Inc.
PUT
$64.1 Million
2.48M
Q3 2025
Added 21.8%
NVO
Novo Nordisk A S
CALL
$49 Million
884K
Q3 2025
Added 98.71%
KRYS
Krystal Biotech, Inc.
PUT
$26.2 Million
149K
Q3 2025
Added 33.87%
VRTX
Vertex Pharmaceuticals Inc
PUT
$21.7 Million
55.3K
Q3 2025
Added 10.44%
VRTX
Vertex Pharmaceuticals Inc
CALL
$15.3 Million
39.1K
Q3 2025
Added 10.44%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$12.5 Million
22.2K
Q3 2025
Added 15.66%
BNTX
Bio N Tech Se
PUT
$11.1 Million
113K
Q3 2025
Added 135.18%
NTLA
Intellia Therapeutics, Inc.
CALL
$8.56 Million
496K
Q3 2025
Added 25.81%
INSM
Insmed Inc
PUT
$6.94 Million
48.2K
Q3 2025
Added 460.99%
INSM
Insmed Inc
CALL
$5.41 Million
37.6K
Q3 2025
Added 460.99%
ETNB
89bio, Inc.
PUT
$5.04 Million
344K
Q3 2025
Added 90.83%
BNTX
Bio N Tech Se
CALL
$4.99 Million
50.6K
Q3 2025
Added 135.18%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$4.79 Million
10.5K
Q3 2025
Reduced 10.17%
CRSP
Crispr Therapeutics Ag
CALL
$2.88 Million
44.5K
Q3 2025
Reduced 17.74%
CRSP
Crispr Therapeutics Ag
PUT
$2.59 Million
40K
Q3 2025
Reduced 17.74%
TVTX
Travere Therapeutics, Inc.
CALL
$2.46 Million
103K
Q3 2025
Reduced 24.18%
RPRX
Royalty Pharma PLC
CALL
$2.12 Million
60K
Q3 2025
Reduced 30.14%
VKTX
Viking Therapeutics, Inc.
CALL
$1.79 Million
70K
Q3 2025
Added 41.07%
SMMT
Summit Therapeutics Inc.
CALL
$1.76 Million
85K
Q3 2025
Reduced 38.93%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$1.36 Million
2.99K
Q3 2025
Reduced 10.17%
CRDF
Cardiff Oncology, Inc.
CALL
$1.28 Million
633K
Q3 2025
Added 4.43%
RPRX
Royalty Pharma PLC
PUT
$1.16 Million
32.8K
Q3 2025
Reduced 30.14%
SNDX
Syndax Pharmaceuticals Inc
CALL
$1.11 Million
72.3K
Q3 2025
Added 16.66%
CNTA
Centessa Pharmaceuticals PLC
CALL
$1.1 Million
45.3K
Q3 2025
Reduced 59.39%
CYTK
Cytokinetics Inc
CALL
$1.09 Million
19.8K
Q3 2025
Reduced 41.27%
ALT
Altimmune, Inc.
CALL
$1.08 Million
286K
Q3 2025
Reduced 27.52%
RXRX
Recursion Pharmaceuticals, Inc.
CALL
$917,000
188K
Q3 2025
Reduced 18.94%
BMRN
Biomarin Pharmaceutical Inc
PUT
$704,000
13K
Q3 2025
Reduced 9.17%
JAZZ
Jazz Pharmaceuticals PLC
CALL
$659,000
5K
Q3 2025
Added 16.17%
BMRN
Biomarin Pharmaceutical Inc
CALL
$444,000
8.2K
Q3 2025
Reduced 9.17%
ARCT
Arcturus Therapeutics Holdings Inc.
PUT
$366,000
19.9K
Q3 2025
Added 189.46%
TGTX
Tg Therapeutics, Inc.
PUT
$289,000
8K
Q3 2025
Added 16.33%
NVAX
Novavax Inc
PUT
$241,000
27.9K
Q3 2025
Added 55.85%
BCRX
Biocryst Pharmaceuticals Inc
PUT
$60,000
8K
Q3 2025
Added 6.29%
Filter Shares Options
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email